Executive Summary

Systematic review teams, clinical guideline groups, and regulatory units spend months manually screening and extracting data from PDFs, a task that grows with the rising annual publication volume and creates a bottleneck for an estimated 1.5M research teams worldwide. At an addressable market of $3.0B (1.5M teams × $2K ACV), the pain is both operational and financial—teams routinely expend hundreds to thousands of labor hours per review that could be reduced with effective automation. You could build a B2B SaaS that automates PDF screening and structured data extraction using an LLM-backed retrieval/QA pipeline, with configurable templates for niche review types (for example, randomized trials or diagnostic studies) and end-to-end audit trails linking extracted fields back to source pages. Include integrations with common review platforms (Covidence, EPPI-Reviewer, REDCap), human-in-the-loop validation, and per-project accuracy metrics so teams can tune precision–recall tradeoffs to meet publication or regulatory needs. The timing is favorable: publication counts are climbing and modern document-understanding models now enable realistic time savings—conservatively 50–80% reduction in screening and extraction time for structured fields. Institutional mandates for evidence synthesis, along with a market score and revenue potential rated 88/100, suggest strong willingness to pay for tools that shorten time-to-insight and reduce labor costs. To differentiate in a medium-competition landscape, focus on rigorous validation against gold-standard datasets, productized templates for high-value niches, transparent provenance for every extracted datum, and enterprise-grade security and auditability. Expect challenges around highly heterogeneous PDF formats, edge-case extractions that require manual review, and customer reluctance to trust fully automated outputs without clear human oversight and measurable accuracy guarantees.

Market Opportunity

Automating PDF screening and data extraction for niche systematic reviews targets a $3.0B = 1.5M research teams × $2K ACV total addressable market with medium saturation and a year-over-year growth rate of 15% YoY — based on uptake of AI research tools and growth in reference management/knowledge management software (industry analyst estimates).

Key trends driving demand: Publication volume growth — the number of papers published annually is increasing, which raises demand for automated screening and extraction to keep reviews feasible.; AI document understanding improvements — modern LLMs plus retrieval/QA pipelines are enabling accurate extraction of structured trial details from PDFs, which converts into time savings for review teams.; Institutional mandates for evidence synthesis — funders and regulators increasingly require systematic evidence reviews, increasing institutional willingness to pay for tooling that reduces cost and time.; Shift to collaborative cloud workflows — research teams expect shared workspaces, versioning and audit trails, creating demand beyond single-user summarizers..

Key competitors include Rayyan, Iris.ai, Scholarcy.

Sign in to access

Automating PDF screening and data extraction for niche systematic reviews

Executive Summary

Market Validation

Market Opportunity

More in B2B Software

Small-business grant discovery — centralized database + automated alerts

Streamline dealership ops — centralize inventory, leads, docs & payments

Early-traction trap: convert one-off signups into repeat video-contract users

Manual quoting & installs — AI visual quoting + field workflow automation

Outdated workflows: autonomous AI agents orchestrating ops & data (pain → AI OS)

Map processes first — prevent automating broken manual workflows